索引于
  • 打开 J 门
  • 学术钥匙
  • 研究圣经
  • 中国知网(CNKI)
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • CABI 全文
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Bacteraemia is a serious complication in chronic liver patients

Farrah Bilal

Patients of chronic liver diseases face a fatal complication known as bacteraemia which leads to gastrointestinal bleeding and hepatic encephalopathy. Bacterial peritonitis and bacteraemia is common in liver cirrhosis but site of infection does not depend to aetiology of the liver disease. Along with bacteraemia, urinary tract infections and respiratory tract infections are the most frequent bacterial infections complications seen in cirrhotic patients. So, clinical suspicion of bacteraemia is an indication of deterioration in the patients, increasing encephalopathy. Streptococci and Gram negative enteric are common organisms that cause infections in liver patients of Pakistan. Therefore, we have been conducted a descriptive research study in various health care centres of Pakistan in duration of three month. The incidence of bacteraemia in cirrhotic patients admitted in hospital with ascites has been estimated to range between 7 and 24%. The diagnosis is performed by polymorphonuclear cell count in ascites fluid higher than 250/mm3. The diagnosis of SIBO is based on the use of glucose breath hydrogen tests or quantitative culture of jejunal aspirate. More than 70% patients have positive culture of bacterial peritonitis and small intestinal bacterial overgrowth (SIBO) has been shown to frequently occur in the setting of chronic liver diseases. Initial results of our study showed that cephalosporins are the most commonly used antibiotic treatment in bacteraemia complication with liver disease.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证